Let's keep the President out of this and stick to serious discussions. Eli Lilly drug gets traditional approval to help treat the disease and symptoms.
Another demonstration of the power of biopharma and medical technology development in the U.S. @BadWakeboarder
Another demonstration of the power of biopharma and medical technology development in the U.S. @BadWakeboarder
Alzheimer’s Association Welcomes U.S. FDA Approval of Kisunla (Donanemab)
The Alzheimer’s Association celebrates today’s FDA approval of Kisunla™ (donanemab) for the treatment of people living with early symptomatic Alzheimer’s.
www.alz.org